论文部分内容阅读
酮康唑(Ketoconazole 商品名 Nizoral)是一种最新的脒唑类衍生物,自1978年应用于临床以来发表了大量临床疗效观察报告,证明酮康唑口服吸收好、无毒、疗效高,既能治疗各种浅部真菌病,又能治疗各种深部真菌病,是目前较有希望的广谱抗真菌药。作者有机会得到一定数量的酮康唑片共治疗皮肤真菌病66例获得极满意效果,现小结如下。一、一般资料:口服酮康唑治疗各种真菌病近百例,其中资料较完整可供临床总结的为66例。男性
Ketoconazole (Nizoral), a new derivative of the amidine azole, has been widely used in clinical practice since its publication in 1978. It has been shown that ketoconazole is orally absorbed, non-toxic and highly effective Can treat a variety of shallow mycosis, but also treat various deep fungal diseases, is the more promising broad-spectrum antifungal agents. The authors have the opportunity to get a certain amount of ketoconazole tablets were treated skin fungal disease 66 cases were extremely satisfied with the results are summarized as follows. First, the general information: Oral ketoconazole treatment of various fungal diseases in nearly 100 cases, of which more complete information available for clinical summary of 66 cases. male